搜索临床试验以:K-Ras wildtype
总计234个结果
-
The George InstituteNational Health and Medical Research Council, Australia完全的
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAmgen; Pivotal S.L.主动,不招人
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAmgen; Pivotal S.L.完全的
-
Novartis Pharmaceuticals完全的
-
Pfizer完全的
-
Henan Cancer Hospital完全的野生型 KRAS、NRAS 和 BRAF V600E 转移性结直肠癌
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbH完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI); Amgen终止IV 期结直肠癌 AJCC v7 | IVA 期结直肠癌 AJCC v7 | IVB 期结直肠癌 AJCC v7 | 结直肠腺癌 | RAS 野生型 | III 期结直肠癌 AJCC v7 | IIIA 期结直肠癌 AJCC v7 | IIIB 期结直肠癌 AJCC v7 | IIIC 期结直肠癌 AJCC v7美国
-
NYU Langone HealthCelldex Therapeutics终止
-
Queen Mary University of LondonAstraZeneca; Cancer Research UK未知鳞状细胞肺癌 | 三阴性乳腺癌 | 具有 KRAS 突变的非鳞状细胞肺癌 | 具有野生型 KRAS 的非鳞状细胞肺癌英国
-
Merck KGaA, Darmstadt, Germany完全的
-
AmgenZeinCRO Hellas SA完全的
-
MedImmune LLC完全的
-
Shanghai Zhangjiang Biotechnology Limited CompanyShanghai Biomabs Pharmaceutical Co., Ltd.完全的
-
First Affiliated Hospital Xi'an Jiaotong UniversityLanZhou University; Shaanxi Provincial People's Hospital; General Hospital of Ningxia Medical... 和其他合作者未知
-
The Netherlands Cancer InstituteAstraZeneca; Boehringer Ingelheim未知
-
Eli Lilly and CompanyNSABP Foundation Inc终止
-
King Faisal Specialist Hospital & Research CenterMerck Sharp & Dohme LLC未知
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Amgen完全的
-
Poudre Valley Health SystemUniversity of Colorado, Denver; Defense Advanced Research Projects Agency完全的
-
First People's Hospital of Hangzhou未知
-
Hans-Joachim Schmoll, MDBiocompatibles UK Ltd终止
-
EMD Serono终止
-
European Organisation for Research and Treatment...Roche Pharma AG; Amgen终止结直肠癌转移 | 肝转移 | KRAS野生型结直肠癌法国, 比利时, 奥地利, 荷兰, 西班牙, 瑞士